Study determines higher dosage of radioembolization to treat liver cancer improves survival rates

A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of using a higher dosage of radioembolization treatment using yttrium-90 (Y-90) microspheres, than previously recommended, for liver cancer. Patients who received this elevated dose had significantly better outcomes than those who did not. The study results, which are potentially practice changing, were published in the journal Liver Cancer in September 2024.

Facebook Comments